Raceland (LA)
{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~16 mi. (Houma, Louisiana, +825 more cities)
facility
Terrebonne General Medical Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~16 mi. (Houma, Louisiana, +954 more cities)
facility
Terrebonne General Medical Center
condition
Non-Small Cell Lung Carcinoma
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
city
~16 mi. (Houma, Louisiana, +507 more cities)
facility
Terrebonne General Medical Center
condition
Melanoma
drug
pembrolizumab
drug type
immunotherapy
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
city
~16 mi. (Houma, Louisiana, +637 more cities)
facility
Terrebonne General Medical Center
biomarker
ER Negative, +2 more biomarkers
condition
Invasive Breast Carcinoma
drug
capecitabine, +2 more drugs
drug type
chemotherapy
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
city
~16 mi. (Houma, Louisiana, +299 more cities)
facility
Terrebonne General Medical Center
condition
Hodgkin Lymphoma
drug
brentuximab vedotin, +2 more drugs
drug type
chemotherapy, +1 more type